The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Formoterol 12 micrograms inhalation powder, hard capsule

Laboratorios LICONSA, S.A.PA1239/001/001

Main Information

Trade NameFormoterol 12 micrograms inhalation powder, hard capsule
Active SubstancesFormoterol fumarate
Dosage FormInhalation powder, hard capsule
Licence HolderLaboratorios LICONSA, S.A.
Licence NumberPA1239/001/001

Group Information

ATC CodeR03AC Selective beta-2-adrenoreceptor agonists
R03AC13 formoterol


License statusAuthorised
Licence Issued14/03/2008
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back